A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Annexon, Inc. stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 59,310 shares of ANNX stock, worth $304,853. This represents 0.0% of its overall portfolio holdings.

Number of Shares
59,310
Previous 34,167 73.59%
Holding current value
$304,853
Previous $167,000 110.18%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$4.49 - $7.2 $112,892 - $181,029
25,143 Added 73.59%
59,310 $351,000
Q2 2024

Aug 14, 2024

BUY
$4.33 - $6.79 $147,943 - $231,993
34,167 New
34,167 $167,000

Others Institutions Holding ANNX

About Annexon, Inc.


  • Ticker ANNX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 47,617,700
  • Market Cap $245M
  • Description
  • Annexon, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapeutics for autoimmune, neurodegenerative, and ophthalmic disorders. The company's C1q is an initiating molecule of the classical complement pathway that targets distinct disease processes, such as antibody-mediated autoimmune disease and complement-mediated n...
More about ANNX
Track This Portfolio

Track Mirae Asset Global Etfs Holdings Ltd. Portfolio

Follow Mirae Asset Global Etfs Holdings Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mirae Asset Global Etfs Holdings Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Mirae Asset Global Etfs Holdings Ltd. with notifications on news.